Cargando…
Identification of Novel Proteins Interacting with Proprotein Convertase Subtilisin/Kexin 9
High levels of cholesterol, especially as low-density lipoprotein (LDL), are a well-known risk factor for atherosclerotic-related diseases. The key atherogenic property of LDL is its ability to form atherosclerotic plaque. Proprotein convertase subtilisin/kexin-9 (PCSK9) is an indirect regulator of...
Autores principales: | Melendez, Quantil M., Wooten, Catherine J., Krishnaji, Sreevidhya T., Knagge, Kevin, Kirchner, David, Lopez, Dayami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316369/ https://www.ncbi.nlm.nih.gov/pubmed/32587953 http://dx.doi.org/10.31531/2581-4745.1000123 |
Ejemplares similares
-
Identification of Proteins Interacting with PCSK9 Using a Protoarray Human Protein Microarray
por: Wooten, Catherine J., et al.
Publicado: (2019) -
Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review
por: Wu, Na-Qiong, et al.
Publicado: (2022) -
Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
por: Wu, Qingyu, et al.
Publicado: (2022) -
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9
por: Chen, I-Chih, et al.
Publicado: (2017) -
Proprotein convertase subtilisin/kexin type 9: an update on the cardiovascular outcome studies
por: Ferri, Nicola, et al.
Publicado: (2020)